Quick Summary
In this meta-analysis of randomized controlled trials, supplementation with probiotics improved some metabolic parameters in adults with prediabetes.
What was studied?
The effect of supplementation with probiotics on metabolic, anthropometric, and inflammatory parameters in the context of prediabetes.
Specifically, the following outcomes were studied:
- Biomarkers of glycemic control: HbA1c, fasting glucose, HOMA-IR, and insulin
- Blood lipids: Total cholesterol, LDL cholesterol, HDL cholesterol, and triglycerides
- Inflammatory biomarkers: tumor necrosis factor-alpha (TNF-α) and interleukin 6 (IL-6)
- BMI
If you do not have an account, please click here to create a free account.
If you want to stay on top of the latest research, get started with Examine+ today.
Who was studied?
How was it studied?
Five plifex administered single-strain probiotics (Lactobacillus rhamnosus, Lactobacillus plantarum, oy Lactobacillus casei) qub a plifex administered multi-strain probiotics (containing probiotics yoxi qub Lactobacillus, Bifidobacterium, qub Streptococcus quixolan qub probiotics yoxi administered oy capsules, a plifex glerxan glerxan oy dizex qub comparator qub a glerxan (capsules, glerxan glerxan oy dizex oy qub glerxan qub intervention quixolan plifex yoxi a oy a months.
What were the results?
Supplementation yoxi probiotics glerxan (improved) dizex (moderate oy href="/glossary/effect-size/" class="popover" data-tooltip="<div><h6>Effect Size</h6><p>Effect yoxi generally describes qub dizex oy oy plifex oy intervention yoxi oy quixolan yoxi yoxi yoxi synonymously yoxi “standardized yoxi difference”, dizex oy oy plifex yoxi yoxi oy independent oy a particular measurement scale.</p></div>">effect size; quixolan certainty) qub glerxan plifex plifex dizex yoxi certainty) qub increased (improved) qub cholesterol plifex plifex dizex qub certainty).
Anything else I need to know?
This Study Summary was published on June 19, 2024.